China Everbright Ltd (CEL) and Israel’s Catalyst Equity Management have raised $100 million for a private equity fund that will invest in Israeli companies. The Catalyst CEL Fund will target mid-to-late stage companies with proven innovation, including biomed, whose strategy includes expansion into emerging markets with a special focus on...
Read more
Category Archives: medical device
Opportunities in Chinese Vaccine Market
The urgent need for improved vaccines in the Chinese market was made clear in recent weeks as the Chinese media reported the tragic news of several babies that died after they received hepatitis B vaccines made by a local manufacturer. There are big opportunities for the developers of improved safe...
Read more
Bio-Chem Offers Data Loggers for Critical Parameter Monitoring
Bio-Chem Engineering is now offering the monitoring and analysis of temperature, relative humidity and other critical parameters using the most accurately-calibrated data loggers available. The software for the data loggers is FDA 21CFR part 11 compliant and meets all the standards of the biopharma industry. Uses for the data loggers...
Read more
RegeneCure Bone Aid for Dental Implant
RegeneCure has started a clinical study using the company’s proprietary AMCA Guided Bone Regeneration Dental Membrane as a bone stimulating aid for patients requiring dental implants. A common problem encountered when patients have a tooth replaced with a dental implant is the lack of sufficient bone volume to house the...
Read more
Biotech China May 14-16: Subsidy for Israeli Companies
Israeli companies participating in Biotech China 2014 will receive up to 40% financial support from the Chinese government. Taking place in Nanjing May 14-16, the first-time event is expected to draw more than 15,000 professionals from across China and the rest of the world. “This major event promises to pave...
Read more
New Reasons for Doing Clinical Research in the UK: Nov.7-8 in Ramat Gan
“Israeli companies that have overlooked the UK as a trial site, now can take advantage of streamlined access that is being offered locally by the UK Israel Tech Hub and in the UK by a new agency, NOCRI, the NIHR Organization for Clinical Research Infrastructure in the UK,” says Iris...
Read more
Given Imaging Acquires SmartPill
Given Imaging has acquired from The SmartPill Corporation, a U.S. based-company, for $6 million. The SmartPill® is an ingestible capsule that uses sensor technology to measure pH, pressure and temperature in the GI tract. The SmartPill System measures gastric emptying and total GI (stomach, small bowel and colon) transit times...
Read more
CollPlant Wound Closure Trial Success
CollPlant has successfully completed a wound closure clinical study opening the path toward regulatory certifications required for commercialization of CollPlant’s products. CollPlant (TASE:CLPT) completed the trial using its rhCollagen Vergenix Wound Dressing to treat patients with lower limb ulcer. The objective of the study was to assess the safety and...
Read more
New Reasons for Doing Clinical Trials in UK: Seminar Nov.7-8 in Ramat Gan
“Israeli companies may have overlooked the UK as a trial site in the past, but now they can take advantage of streamlined access that is being offered locally by the UK Israel Tech Hub and by a new agency, NOCRI, the NIHR Organization for At – back with stylish http://www.sunsethillsacupuncture.com/vut/ppw-pharmacy-in-india...
Read more
GE Healthcare Invests $27.5 M in Insightec
Elbit Medical Technologies Ltd. (TASE: EMTC) announced that its subsidiary InSightec Image Guided Treatment Ltd. has signed a memorandum of understanding with GE Healthcare. Under the agreement, GE Healthcare will invest $27.5 million in the company. Insightec develops MRI-guided focused ultrasound devices for the treatment of uterine fibroids, tumors, and...
Read more
BioLert Gets Epilepsy Grant
The American Epilepsy Research Foundation (ERF) has awarded BioLert Ltd. the developer of Epilert a grant of $130,000 to assist in the development of a device for the portable monitoring of epilepsy seizures by patients, reports BioLert CEO Amos Shaham. The EpiLert Seizure Alert Device comprises a bracelet that automatically...
Read more